Rajeev Saggar is Chief Medical Officer at Liquidia Corp (LQDA). They have made 4 open-market trades across 1 company since 2023, most recently 2026-10-12.
CIK 0001935638
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LQDA | 126,368 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2026-10-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LQDA | SELL · 10b5-1 | 2026-10-12 | 2026-10-13 | $28.48 | $263K | — | — | — |
| LQDA | SELL | 2026-08-17 | 2026-08-19 | $75.09 | $6.0M | -7.3% | -9.1% | — |
| LQDA | SELL · 10b5-1 | 2026-07-13 | 2026-07-14 | $71.51 | $710K | +13.3% | -5.3% | -63.7% |
| LQDA | SELL · 10b5-1 | 2026-04-13 | 2026-04-14 | $38.37 | $354K | -4.1% | +52.2% | +83.2% |
| LQDA | SELL | 2026-03-13 | 2026-03-17 | $36.30 | $2.6M | -5.6% | +11.5% | +93.3% |
| LQDA | SELL | 2026-01-12 | 2026-01-13 | $37.43 | $791K | +10.2% | +1.9% | +1.4% |
| LQDA | SELL | 2025-11-05 | 2025-11-07 | $27.00 | $1.9M | +12.4% | +32.7% | +57.5% |
| LQDA | SELL · 10b5-1 | 2025-10-13 | 2025-10-15 | $23.41 | $249K | -2.3% | +20.3% | +63.5% |
| LQDA | SELL · 10b5-1 | 2025-08-28 | 2025-09-02 | $27.85 | $557K | -8.0% | -22.5% | +13.5% |
| LQDA | SELL · 10b5-1 | 2025-07-21 | 2025-07-23 | $14.54 | $37K | +9.7% | +51.1% | +32.8% |
| LQDA | SELL · 10b5-1 | 2025-07-14 | 2025-07-15 | $14.28 | $152K | +34.6% | +79.2% | +63.3% |
| LQDA | SELL · 10b5-1 | 2025-06-04 | 2025-06-05 | $16.97 | $258K | -25.5% | -31.7% | +60.2% |
| LQDA | SELL · 10b5-1 | 2025-04-21 | 2025-04-23 | $13.67 | $33K | +19.5% | +13.8% | +23.1% |
| LQDA | SELL · 10b5-1 | 2025-04-14 | 2025-04-16 | $13.57 | $101K | -1.5% | +37.6% | +5.8% |
| LQDA | SELL · 10b5-1 | 2025-01-21 | 2025-01-23 | $13.00 | $32K | +5.7% | +10.9% | -5.4% |
| LQDA | SELL · 10b5-1 | 2025-01-14 | 2025-01-14 | $11.78 | $147K | +21.5% | +40.0% | +19.9% |
| LQDA | SELL · 10b5-1 | 2024-10-18 | 2024-10-22 | $11.19 | $28K | -2.0% | -9.4% | +21.6% |
| LQDA | SELL · 10b5-1 | 2024-10-14 | 2024-10-15 | $11.11 | $25K | -5.2% | -13.7% | +1.3% |
| LQDA | SELL · 10b5-1 | 2024-07-19 | 2024-07-22 | $11.13 | $21K | +1.8% | -12.4% | -2.6% |
| LQDA | SELL · 10b5-1 | 2024-07-12 | 2024-07-15 | $12.53 | $18K | -10.1% | +7.8% | -12.7% |
| LQDA | SELL · 10b5-1 | 2024-04-19 | 2024-04-23 | $13.68 | $23K | -1.4% | -1.0% | -12.4% |
| LQDA | SELL · 10b5-1 | 2024-04-12 | 2024-04-16 | $14.58 | $22K | -6.8% | -5.2% | -7.4% |
| LQDA | SELL · 10b5-1 | 2024-03-18 | 2024-03-19 | $15.82 | $212K | -6.8% | -13.7% | -16.7% |
| LQDA | SELL · Routine | 2023-12-18 | 2023-12-18 | $7.42 | $110K | +56.2% | +74.4% | +102.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.